Atogepant, the first oral preventive treatment for chronic migraine. 2023

Kristian A Haanes, and Lars Edvinsson
Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet-Glostrup, 2600 Glostrup, Denmark. Electronic address: kristian.agmund.haanes@regionh.dk.

UI MeSH Term Description Entries
D008881 Migraine Disorders A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) Acute Confusional Migraine,Headache, Migraine,Status Migrainosus,Abdominal Migraine,Cervical Migraine Syndrome,Hemicrania Migraine,Migraine,Migraine Headache,Migraine Variant,Sick Headache,Abdominal Migraines,Acute Confusional Migraines,Cervical Migraine Syndromes,Disorder, Migraine,Disorders, Migraine,Headache, Sick,Headaches, Migraine,Headaches, Sick,Hemicrania Migraines,Migraine Disorder,Migraine Headaches,Migraine Syndrome, Cervical,Migraine Syndromes, Cervical,Migraine Variants,Migraine, Abdominal,Migraine, Acute Confusional,Migraine, Hemicrania,Migraines,Migraines, Abdominal,Migraines, Acute Confusional,Migraines, Hemicrania,Sick Headaches,Variant, Migraine,Variants, Migraine
D010880 Piperidines A family of hexahydropyridines.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D015740 Calcitonin Gene-Related Peptide A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Calcitonin Gene-Related Peptide I,Calcitonin Gene-Related Peptide II,alpha-CGRP,alpha-Calcitonin Gene-Related Peptide,beta-CGRP,beta-Calcitonin Gene-Related Peptide,Calcitonin Gene Related Peptide,Calcitonin Gene Related Peptide I,Calcitonin Gene Related Peptide II,Gene-Related Peptide, Calcitonin,alpha Calcitonin Gene Related Peptide,beta Calcitonin Gene Related Peptide

Related Publications

Kristian A Haanes, and Lars Edvinsson
August 2021, The New England journal of medicine,
Kristian A Haanes, and Lars Edvinsson
April 2022, Expert opinion on pharmacotherapy,
Kristian A Haanes, and Lars Edvinsson
August 2022, Drugs of today (Barcelona, Spain : 1998),
Kristian A Haanes, and Lars Edvinsson
February 2011, Current pain and headache reports,
Kristian A Haanes, and Lars Edvinsson
November 2021, The Medical letter on drugs and therapeutics,
Kristian A Haanes, and Lars Edvinsson
November 2017, The New England journal of medicine,
Kristian A Haanes, and Lars Edvinsson
August 2022, Trends in pharmacological sciences,
Copied contents to your clipboard!